Get started
Author

Takafumi Yamamoto

Combustion characteristics of sewage sludge in an incineration plant for energy recovery
2009 · Takahiro Murakami, Yoshizo Suzuki, et al. · Fuel Processing Technology · 199
Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies
2021 · Takanori Ito, Masatoshi Ishigami, et al. · Hepatology International · 40
PDF
Mucin Expression in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Specimens Is a Useful Prognostic Factor in Pancreatic Ductal Adenocarcinoma
2015 · Michiyo Higashi, Seiya Yokoyama, et al. · Pancreas · 34
Fully automatic measuring system for assessing masticatory performance using β‐carotene‐containing gummy jelly
2012 · T. Nokubi, S. Yasui, et al. · Journal of Oral Rehabilitation · 29
A Rare Case of Gastric Lipoma with Early Gastric Cancer
2004 · Takafumi YAMAMOTO, Kazuyuki IMAKIIRE, et al. · Internal Medicine · 29
PDF
Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real‑world practice
2024 · Shigeo Shimose, Issei Saeki, et al. · Oncology Letters · 24
PDF
Multiseptate gallbladder with anomalous pancreaticobiliary ductal union: A case report
2005 · Takafumi Yamamoto · World Journal of Gastroenterology · 22
PDF
Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy
2024 · Issei Saeki, Shigeo Shimose, et al. · PLoS ONE · 21
PDF
Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
2021 · Takafumi Yamamoto, Takanori Ito, et al. · Cancer Investigation · 21
Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
2023 · Reika Yamauchi, Takanori Ito, et al. · Journal of Gastroenterology · 20
Gastroesophageal reflux symptoms in adults with skeletal Class III malocclusion examined by questionnaires
2009 · Rena Togawa, Haruhito Ohmure, et al. · American Journal of Orthodontics and Dentofacial Orthopedics · 18
Helicobacter heilmannii Associated Erosive Gastritis.
1999 · Takafumi YAMAMOTO, Jun MATSUMOTO, et al. · Internal Medicine · 18
PDF
A Calligraphy Mastering Support System Using Virtual Reality Technology and its Learning Effects
2003 · Noriaki Muranaka, Takafumi Yamamoto, et al. · IEEJ Transactions on Fundamentals and Materials · 15
PDF
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan
2025 · Shigeo Shimose, Issei Saeki, et al. · Hepatology International · 14
Clustering using unsupervised machine learning to stratify the risk of immune‐related liver injury
2022 · Takafumi Yamamoto, Hikaru Morooka, et al. · Journal of Gastroenterology and Hepatology · 14
PDF
Factors affecting masticatory performance during the mixed dentition period
2022 · Masako Shiramizu, Yoko Hasegawa, et al. · Journal of Oral Rehabilitation · 13
Spinal cord infarction following endoscopic variceal ligation
2007 · K Tofuku, H Koga, et al. · Spinal Cord · 11
Clinical characteristics of immune checkpoint inhibitor-related pancreatic injury with pancreatitis in patients with advanced malignancies
2025 · Takaya Suzuki, Kazuyuki Mizuno, et al. · Digestive and Liver Disease · 10
PDF
Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis
2023 · Takafumi Yamamoto, Kazuyuki Mizuno, et al. · Investigational New Drugs · 10
PDF
Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma
2023 · Kazuyuki Mizuno, Norihiro Imai, et al. · Cancers · 8
PDF
Spinal Cord Compression Secondary to Osteoblastic Metastasis
1993 · Eiji Wada, Takafumi Yamamoto, et al. · Spine · 8
Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child–Pugh Class B
2025 · Ryu Sasaki, Shigeo Shimose, et al. · Liver International · 7
PDF
Outcomes of immune checkpoint inhibitor‐induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team
2024 · Takanori Ito, Kazuyuki Mizuno, et al. · Hepatology Research · 7
Clinical features and pathological findings by liver biopsy in patients with immune-related sclerosing cholangitis induced by immune checkpoint inhibitors
2025 · Tsukasa Yasuda, Takanori Ito, et al. · Digestive and Liver Disease · 6
PDF
Changes in Body Composition Predict the Time to Treatment Failure of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma: A Pilot Retrospective Study
2022 · Takafumi Yamamoto, Norihiro Imai, et al. · Nutrition and Cancer · 6
Works count: 84
Citation count: 662
H-index: 14
I10-index: 19
Year
Topic
Type